Suchergebnisse - "Rothenberg, Michael E."

PubPharm (6)

1

A phase I, randomized, ascending-dose study to assess safety, pharmacokinetics, and activity of GDC-8264, a RIP1 inhibitor, in healthy volunteers

enthalten in: Clinical and translational science | 2023

von Jones, N. | Kshirsagar, S. | Mohanan, V. | +11

2

Dose escalation randomised study of efmarodocokin alfa in healthy volunteers and patients with ulcerative colitis

enthalten in: Gut | 2023

von Wagner, F. | Mansfield, J. | Lekkerkerker, A. | +9

3

A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS

enthalten in: Annals of clinical and translational neurology | 2022

von Katz, J. | Rothstein, J. | Cudkowicz, M. | +20

4

Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers

enthalten in: Clinical drug investigation | 2019

von Rothenberg, M. | Tagen, M. | Chang, J. | +7

ErratumIn: Clin Drug Investig. 2019 Jul 23;:. - PMID 31338799

5

A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-Staphylococcus aureus Thiomab Antibody-Antibiotic Conjugate, in Healthy Volunteers

enthalten in: Antimicrobial agents and chemotherapy | 2019

von Peck, M. | Rothenberg, M. | Deng, R. | +10

6

Randomized Phase I Healthy Volunteer Study of UTTR1147A (IL-22Fc) : A Potential Therapy for Epithelial Injury

enthalten in: Clinical pharmacology and therapeutics | 2019

von Rothenberg, M. | Wang, Y. | Lekkerkerker, A. | +6

1
[1]